AstraZeneca shares slump after $400bn BMS merger rumours
AstraZeneca shares slump after $400bn BMS merger rumours
Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.comSummary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.